WTC@H?!
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

WTC@H?! Trademark

Serial Number: 98421438

WTC@H?! is a trademark filed by Neurocrine Biosciences, Inc. on February 26, 2024. The trademark is classified under Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Neurocrine Biosciences, Inc. (238 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

February 26, 2024

Registration Date

Not Registered

Published for Opposition

April 8, 2025

Goods & Services

Promoting awareness of congenital adrenal hyperplasia by providing a public online platform in the nature of an online forum to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency by providing a public online platform in the nature of an online forum to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders by providing a public online platform in the nature of an online forum to discuss endocrine diseases and disorders and coping strategies

Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of endocrine diseases and disorders

Promoting awareness of congenital adrenal hyperplasia and promoting awareness of congenital adrenal hyperplasia by providing a public in-person platform to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency and promoting awareness of adrenal insufficiency by providing a public in-person platform to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders and promoting awareness of endocrine diseases and disorders by providing a public in-person platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders

Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2026 EXRA
SOU EXTENSION 2 GRANTED
May 15, 2026 EX2G
SOU EXTENSION 2 FILED
May 15, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
May 15, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 3, 2025 EX1G
SOU EXTENSION 1 FILED
Dec 3, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 3, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 3, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 2, 2025 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2025 COAR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 14, 2025 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 14, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 14, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 14, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 14, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2025 CRFA
ASSIGNED TO LIE
Mar 7, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 12, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 12, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 28, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 28, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 28, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 5, 2024 NWOS
NEW APPLICATION ENTERED
Feb 26, 2024 NWAP